Amazon Quick Research integrates biomedical databases for rare cancer breakthroughs

Amazon Quick Research tackles the fragmentation in rare cancer research by automating the integration of heterogeneous data sources—genomic sequencing, clinical trials, biomarker repositories, and literature. Traditional approaches require custom ETL pipelines and manual schema reconciliation, taking weeks. Quick Research ingests both structured and unstructured data from public biomedical databases (e.g., PubMed) and user-uploaded files (PDF, Word, Excel, PowerPoint, etc.) into a unified environment called Spaces. It then applies LLM-driven synthesis to produce structured, cited reports with inline citations traceable to source documents. The workflow includes research objective parsing, multi-source data ingestion, an AI-generated research plan that users can review and revise, and a versioned revision system that allows annotation and incremental updates. The walkthrough uses pediatric sarcoma as a use case, demonstrating how to create a Space, configure data sources, run the investigation, and export reports as PDF or Word. The service is paid, with cleanup steps to avoid ongoing charges.

Key capabilities include a research agent that interprets natural language queries and breaks them into parallel sub-topics, supports web search and file uploads, and generates reports with executive, general, or custom summaries. The versioned revision workflow lets researchers annotate specific statements with up to 400-character comments, triggering a new run scoped to those sections while preserving prior versions. Spaces, the data organization layer, can group up to 10,000 files alongside Quick dashboards and knowledge bases. Supported file formats include CSV, TXT, JSON, YAML, XML, and HTML. For rare cancer research, this means clinicians and scientists can rapidly synthesize evidence from disparate databases, reducing months of data wrangling to hours of focused analysis.